Gregory D. Gutierrez, Ph.D.

Dr. Gregory Gutierrez is an associate in Goodwin’s Life Sciences and Technology groups. He joined Goodwin in 2017.

Greg advises companies and investors on intellectual property matters for life sciences and chemical innovations. His practice includes the design and implementation of global patent estates for product life cycles, evaluating competitive landscapes and freedom to operate, and intellectual property due diligence for complex transactions including financings, IPOs, and M&A.

Greg’s experience includes devising patent strategies for inventions across several therapeutic spaces, including small molecules, drug conjugates, and compositions for medical implants. To this end, he has worked extensively with clients to build patent portfolios for product candidates through various stages of clinical development, including multiple FDA-approved therapeutics. He also leverages his research background in materials chemistry and polymer science to advise clients developing environmentally sustainable technologies and next-generation materials for electronic devices. Greg was previously a science advisor and law clerk at Goodwin.